Skip to main content
Premium Trial:

Request an Annual Quote

Arthur Beaudet, Laura van ‘t Veer, Martine Piccart-Gebhardt, Fatima Cardoso, Beppe Viale, Ellen Beasley, Keith Joho, Jeff Otto, John Sluis, Jay Moyes, Jim Evans

Arthur Beaudet, chair and professor of molecular and human genetics at Baylor College of Medicine, has won the American Society of Human Genetics’ Allan Award.
Beaudet is focused on epigenetics in human disease and genomic imprinting and diseases associated with mental retardation and autism.

Laura van ‘t Veer, who is chief research officer at Agendia, has won the 2007 Breast Cancer Research Award from the Pink Ribbon Breast Cancer Foundation, Agendia said last week.
Van ‘t Veer won the award along with her colleagues Martine Piccart-Gebhardt, Fatima Cardoso, and Beppe Viale for their work in a European trial testing the MammaPrint breast cancer assay.

Perlegen last week said it has tapped three new executives to join its staff, including Ellen Beasley, Keith Joho, and Jeff Otto.
Beasley will join the company as VP of project management. She comes to the company from Celera, where she held the posts of senior director of therapeutics alliances, senior director of bioinformatics, and director of gene discovery.
Joho steps in as chief information officer after serving as senior VP of research and product management at Ingenuity Systems, and as VP of informatics and bioanalytical operations at SurroMed. Joho also was director of bioinformatics at Abgenix and was at Roche and at the Louisiana State University Medical Center in New Orleans.
Otto comes to the company to take over the role of VP of production operations after having been an executive at Genaissance Pharmaceuticals and at Sequenom.

Cepheid CFO John Sluis will retire on Dec. 31, the company said in its quarterly earnings statement last week. The company is seeking a replacement for Sluis, who will remain a consultant for Cepheid through 2008. Sluis joined Cepheid as VP of finance and CFO.

Myriad Genetics said last week that Jay Moyes will retire from his job as CFO “to pursue his passion – race car driving.” Moyes will be replaced by Jim Evans, who is currently VP of finance at the company.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.